Executive Director, HIV Treatment Marketing at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Dynamic, experienced individual with a strong track record of commercial success in the pharmaceutical or biopharmaceutical industry
Strong leadership skills with ability to set a vision and impactful brand strategy
Drive innovation and performance within a fast-moving commercial environment
Proven success in alliance management, product launches, and experience within the U.S. market
Key competencies: Results orientation (thrive in fast-paced, high-growth environment, drive to meet/exceed goals, hold others accountable, disciplined processes, contingency plans); Vision (define objectives/priorities, establish milestones through market understanding and innovation)

Responsibilities

Overseeing the development and implementation of strategic and tactical marketing plans for ISL-LEN and the Long-acting HIV treatment market
Successfully managing the partnership with a 3rd party in the US and maintaining close alignment with the ED for HIV Treatment Marketing responsible for QD assets
Achieving revenue targets
Understanding payer access landscape and partnering with managed markets to drive strategy and ensure access and pull-through
Managing and leading a team of marketing professionals—developing, coaching, and managing key functional staff and inspiring and developing talent
Collaborating with the global team and the sales leaders to ensure a coordinated approach
Leading cross-functionally with Legal, Medical, Clinical, Regulatory, Managed Markets, Public Affairs, Compliance and other functions
Cultivating relationships with thought leaders, key customers, and professional organizations
Working in close conjunction with marketing operations to establish appropriate procedures, systems, metrics and infrastructures
Managing Marketing OpEx and marketing mix optimization
Representing ISL-LEN marketing position on Promotional Review Committee and ISL-LEN Global Commercial Team

Skills

HIV Marketing

Pharmaceutical Launch

Commercial Strategy

Franchise Leadership

Product Launch Execution

Biopharmaceutical Marketing

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free